4164 Stock Overview
CHC Healthcare Group, together with its subsidiaries, engages in the trading of pharmaceutical products and health food in Taiwan, China, and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 3/6 |
Dividends | 3/6 |
CHC Healthcare Group Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$60.40 |
52 Week High | NT$75.70 |
52 Week Low | NT$52.00 |
Beta | 0.43 |
1 Month Change | -0.33% |
3 Month Change | 0.50% |
1 Year Change | -7.22% |
3 Year Change | 54.87% |
5 Year Change | 63.24% |
Change since IPO | -33.99% |
Recent News & Updates
Recent updates
If You Had Bought CHC Healthcare Group's (TPE:4164) Shares Five Years Ago You Would Be Down 36%
Mar 08CHC Healthcare Group's (TPE:4164) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 07Should CHC Healthcare Group (TPE:4164) Be Part Of Your Dividend Portfolio?
Jan 21Is CHC Healthcare Group (TPE:4164) Likely To Turn Things Around?
Jan 06Is CHC Healthcare Group (TPE:4164) Using Too Much Debt?
Dec 22CHC Healthcare Group (TPE:4164) Share Prices Have Dropped 32% In The Last Five Years
Dec 07Are CHC Healthcare Group's (TPE:4164) Statutory Earnings A Good Guide To Its Underlying Profitability?
Nov 22Shareholder Returns
4164 | TW Healthcare | TW Market | |
---|---|---|---|
7D | 2.9% | 1.3% | 2.7% |
1Y | -7.2% | -1.6% | 25.7% |
Return vs Industry: 4164 underperformed the TW Healthcare industry which returned -1.6% over the past year.
Return vs Market: 4164 underperformed the TW Market which returned 25.7% over the past year.
Price Volatility
4164 volatility | |
---|---|
4164 Average Weekly Movement | 4.0% |
Healthcare Industry Average Movement | 4.0% |
Market Average Movement | 4.2% |
10% most volatile stocks in TW Market | 8.0% |
10% least volatile stocks in TW Market | 1.9% |
Stable Share Price: 4164 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4164's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1977 | n/a | Pei-Lin Lee | https://www.chcg.com |
CHC Healthcare Group, together with its subsidiaries, engages in the trading of pharmaceutical products and health food in Taiwan, China, and internationally. It also sells, leases, installs, and repairs medical instruments. In addition, the company is involved in the provision of healthcare management service, such as educational training and implementing application programs for medical equipment, and management consultation, as well as overseas healthcare business development.
CHC Healthcare Group Fundamentals Summary
4164 fundamental statistics | |
---|---|
Market cap | NT$10.05b |
Earnings (TTM) | NT$418.87m |
Revenue (TTM) | NT$3.88b |
24.0x
P/E Ratio2.6x
P/S RatioIs 4164 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4164 income statement (TTM) | |
---|---|
Revenue | NT$3.88b |
Cost of Revenue | NT$2.81b |
Gross Profit | NT$1.07b |
Other Expenses | NT$649.29m |
Earnings | NT$418.87m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 2.52 |
Gross Margin | 27.55% |
Net Profit Margin | 10.80% |
Debt/Equity Ratio | 73.5% |
How did 4164 perform over the long term?
See historical performance and comparison